Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events - Meta-analysis of three studies involving 995 patients

被引:57
作者
Akkerhuis, KM
Klootwijk, PAJ
Lindeboom, W
Umans, VAWM
Meij, S
Kint, PP
Simoons, ML
机构
[1] Univ Rotterdam Hosp, Thoraxctr, NL-3015 GD Rotterdam, Netherlands
[2] Cardialysis Lab, Rotterdam, Netherlands
[3] Clin Res Management & Core Labs, Rotterdam, Netherlands
[4] Med Ctr Alkmaar, Div Cardiol, Alkmaar, Netherlands
关键词
electrocardiography; ischaemia; acute coronary syndromes; unstable angina; ECG monitoring; prognosis;
D O I
10.1053/euhj.2001.2750
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Recurrent ischaemia, detected by continuous ECG monitoring, in patients with unstable angina increases the risk of unfavourable outcome. Studies that evaluated this relationship have been limited by the small series of patients. By combining data from three studies, the present analysis aims to provide an accurate assessment of the impact of recurrent ischaemia detected by multilead ECG-ischaemia monitoring on the occurrence of death and myocardial infarction in patients with acute coronary syndromes. Methods and Results Data were obtained from CAPTURE, PURSUIT and FROST, three trials evaluating glycoprotein IIb/IIIa blockers in patients with non-ST-elevation acute coronary syndromes. Patients were monitored for 24 li after enrolment with a computer-assisted 12-lead or a vectorcardiographic ECG-ischaemia monitoring device. In a retrospective blinded analysis, recurrent ischaemic episodes were identified by a computer algorithm. The number of ischaemic episodes was normalized to 24 h. Ischaemic episodes were detected in 271 (27%) of 995 patients. There was a direct proportional relationship between the number of ischaemic episodes per 24 h and the probability of cardiac events at 5 and 30 days. The 30-day composite of death and myocardial infarction occurred in 5-7% of patients without episodes and increased to 19-7% in patients with greater than or equal to5 episodes. After adjustment for baseline predictors of adverse outcome, the relative risk of death or myocardial infarction at 5 and 30 days increased by 25% for each additional ischaemic episode per 24 h. Conclusions This analysis emphasizes the need for integration of multilead ECG-ischaemia monitoring systems in coronary care units and emergency wards to improve early risk stratification in patients with acute coronary syndromes. (C) 2001 The European Society of Cardiology.
引用
收藏
页码:1997 / 2006
页数:10
相关论文
共 29 条
[1]   Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: Relation with death and myocardial infarction [J].
Akkerhuis, KM ;
Maas, ACP ;
Klootwijk, PAJ ;
Krucoff, MW ;
Meij, S ;
Califf, RM ;
Simoons, ML .
JOURNAL OF ELECTROCARDIOLOGY, 2000, 33 (02) :127-136
[2]   Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation - A phase II study [J].
Akkerhuis, KM ;
Neuhaus, KL ;
Wilcox, RG ;
Vahanian, A ;
Boland, JL ;
Hoffmann, J ;
Baardman, T ;
Nehmiz, G ;
Roth, U ;
Klootwijk, APJ ;
Deckers, JW ;
Simoons, ML .
EUROPEAN HEART JOURNAL, 2000, 21 (24) :2042-2055
[3]  
ARNIM TV, 1988, EUR HEART J, V8, P435
[4]   Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes -: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention [J].
Boersma, E ;
Akkerhuis, KM ;
Théroux, P ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
CIRCULATION, 1999, 100 (20) :2045-2048
[5]   Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients [J].
Boersma, E ;
Pieper, KS ;
Steyerberg, EW ;
Wilcox, RG ;
Chang, WC ;
Lee, KL ;
Akkerhuis, KM ;
Harrington, RA ;
Deckers, JW ;
Armstrong, PW ;
Lincoff, AM ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
CIRCULATION, 2000, 101 (22) :2557-2567
[6]   DYNAMIC ONLINE VECTORCARDIOGRAPHY IMPROVES AND SIMPLIFIES IN-HOSPITAL ISCHEMIA MONITORING OF PATIENTS WITH UNSTABLE ANGINA [J].
DELLBORG, M ;
MALMBERG, K ;
RYDEN, L ;
SVENSSON, AM ;
SWEDBERG, K .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (06) :1501-1507
[7]  
DOWER G E, 1980, Clinical Cardiology, V3, P87
[8]   AN ACCURATE, CLINICALLY PRACTICAL SYSTEM FOR SPATIAL VECTORCARDIOGRAPHY [J].
FRANK, E .
CIRCULATION, 1956, 13 (05) :737-749
[9]   SILENT ISCHEMIA AS A MARKER FOR EARLY UNFAVORABLE OUTCOMES IN PATIENTS WITH UNSTABLE ANGINA [J].
GOTTLIEB, SO ;
WEISFELDT, ML ;
OUYANG, P ;
MELLITS, ED ;
GERSTENBLITH, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (19) :1214-1219
[10]   Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels [J].
Hamm, CW ;
Heeschen, C ;
Goldmann, B ;
Vahanian, A ;
Adgey, J ;
Miguel, CM ;
Rutsch, W ;
Berger, J ;
Kootstra, J ;
Simoons, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1623-1629